Evidence map›Paper›PMID 36709030›Full record

ArticleEnvironmental research2023

Highly socially vulnerable communities exhibit disproportionately increased viral loads as measured in community wastewater.

William M Baldwin, Robert D Dayton, Aaron W Bivins, Rona S Scott, Andrew D Yurochko, John A Vanchiere, Terry Davis, Connie L Arnold, Jose E T Asuncion, Mohammad A N Bhuiyan and 7 more

Open access · hybridAbstract read
In one paragraph

Article in Environmental research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

William M BaldwinDepartment of Pharmacology, Toxicology & Neuroscience, School of Graduate Studies, Louisiana State University Health Sciences Center at Shreveport, Shreveport, Louisiana, USA; Louisiana Addiction Research Center, Louisiana State University Health Sciences Center at Shreveport, Shreveport, Louisiana, USA; Center of Excellence for Emerging Viral Threats, Louisiana State University Health Sciences Center at Shreveport, Shreveport, Louisiana, USA.
Robert D DaytonDepartment of Pharmacology, Toxicology & Neuroscience, School of Graduate Studies, Louisiana State University Health Sciences Center at Shreveport, Shreveport, Louisiana, USA; Louisiana Addiction Research Center, Louisiana State University Health Sciences Center at Shreveport, Shreveport, Louisiana, USA; Center of Excellence for Emerging Viral Threats, Louisiana State University Health Sciences Center at Shreveport, Shreveport, Louisiana, USA.
Aaron W BivinsDepartment of Civil and Environmental Engineering, Louisiana State University, Baton Rouge, Louisiana, USA.
Rona S ScottCenter of Excellence for Emerging Viral Threats, Louisiana State University Health Sciences Center at Shreveport, Shreveport, Louisiana, USA; Department of Microbiology and Immunology, Louisiana State University Health Sciences Center at Shreveport, Shreveport, Louisiana, USA.
Andrew D YurochkoLouisiana Addiction Research Center, Louisiana State University Health Sciences Center at Shreveport, Shreveport, Louisiana, USA; Center of Excellence for Emerging Viral Threats, Louisiana State University Health Sciences Center at Shreveport, Shreveport, Louisiana, USA; Division of Health Disparities, Department of Medicine, School of Medicine, Louisiana State University Health Sciences Center at Shreveport, Shreveport, Louisiana, USA.
John A VanchiereLouisiana Addiction Research Center, Louisiana State University Health Sciences Center at Shreveport, Shreveport, Louisiana, USA; Center of Excellence for Emerging Viral Threats, Louisiana State University Health Sciences Center at Shreveport, Shreveport, Louisiana, USA; Division of Infectious Diseases, Department of Pediatrics, School of Medicine, Louisiana State University Health Sciences Center at Shreveport, Shreveport, Louisiana, USA.
Terry DavisLouisiana Addiction Research Center, Louisiana State University Health Sciences Center at Shreveport, Shreveport, Louisiana, USA; Center of Excellence for Emerging Viral Threats, Louisiana State University Health Sciences Center at Shreveport, Shreveport, Louisiana, USA; Division of Health Disparities, Department of Medicine, School of Medicine, Louisiana State University Health Sciences Center at Shreveport, Shreveport, Louisiana, USA.
Connie L ArnoldLouisiana Addiction Research Center, Louisiana State University Health Sciences Center at Shreveport, Shreveport, Louisiana, USA; Center of Excellence for Emerging Viral Threats, Louisiana State University Health Sciences Center at Shreveport, Shreveport, Louisiana, USA; Division of Health Disparities, Department of Medicine, School of Medicine, Louisiana State University Health Sciences Center at Shreveport, Shreveport, Louisiana, USA.
Jose E T AsuncionDepartment of Public Health, School of Allied Health Professions, Louisiana State University Health Sciences Center at Shreveport, Shreveport, Louisiana, USA.
Mohammad A N BhuiyanLouisiana Addiction Research Center, Louisiana State University Health Sciences Center at Shreveport, Shreveport, Louisiana, USA; Center of Excellence for Emerging Viral Threats, Louisiana State University Health Sciences Center at Shreveport, Shreveport, Louisiana, USA; Division of Clinical Informatics, Department of Medicine, School of Medicine, Louisiana State University Health Sciences Center at Shreveport, Shreveport, Louisiana, USA.
Brandon SneadDepartment of Water and Sewage, City of Shreveport, Shreveport, Louisiana, USA.
William DanielDepartment of Water and Sewage, City of Shreveport, Shreveport, Louisiana, USA.
Deborah G SmithLouisiana Addiction Research Center, Louisiana State University Health Sciences Center at Shreveport, Shreveport, Louisiana, USA; Department of Public Health, School of Allied Health Professions, Louisiana State University Health Sciences Center at Shreveport, Shreveport, Louisiana, USA.
Nicholas E GoedersDepartment of Pharmacology, Toxicology & Neuroscience, School of Graduate Studies, Louisiana State University Health Sciences Center at Shreveport, Shreveport, Louisiana, USA; Louisiana Addiction Research Center, Louisiana State University Health Sciences Center at Shreveport, Shreveport, Louisiana, USA; Department of Psychiatry & Behavioral Medicine, School of Medicine, Louisiana State University Health Sciences Center at Shreveport, Shreveport, Louisiana, USA.
Christopher G KevilLouisiana Addiction Research Center, Louisiana State University Health Sciences Center at Shreveport, Shreveport, Louisiana, USA; Center of Excellence for Emerging Viral Threats, Louisiana State University Health Sciences Center at Shreveport, Shreveport, Louisiana, USA; Department of Pathology, School of Medicine, Louisiana State University Health Sciences Center at Shreveport, Shreveport, Louisiana, USA; Department of Molecular and Cellular Physiology, School of Graduate Studies, Louisiana State University Health Sciences Center at Shreveport, Shreveport, Louisiana, USA; Department of Cell Biology and Anatomy, School of Graduate Studies, Louisiana State University Health Sciences Center at Shreveport, Shreveport, Louisiana, USA.
Jennifer CarrollCenter of Excellence for Emerging Viral Threats, Louisiana State University Health Sciences Center at Shreveport, Shreveport, Louisiana, USA.
Kevin S MurnaneDepartment of Pharmacology, Toxicology & Neuroscience, School of Graduate Studies, Louisiana State University Health Sciences Center at Shreveport, Shreveport, Louisiana, USA; Louisiana Addiction Research Center, Louisiana State University Health Sciences Center at Shreveport, Shreveport, Louisiana, USA; Center of Excellence for Emerging Viral Threats, Louisiana State University Health Sciences Center at Shreveport, Shreveport, Louisiana, USA; Department of Psychiatry & Behavioral Medicine, School of Medicine, Louisiana State University Health Sciences Center at Shreveport, Shreveport, Louisiana, USA; Department of Cell Biology and Anatomy, School of Graduate Studies, Louisiana State University Health Sciences Center at Shreveport, Shreveport, Louisiana, USA. Electronic address: kevin.murnane@lsuhs.edu.
Louisiana State University in Shreveport · USLouisiana State University Health Sciences Center Shreveport · USLouisiana State University · US

Funding

Tracking & Evaluation CoreU54GM104940 · NIGMS · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI Leigh Lamonica · 2012 to 2026
$69.1M
The Administrative CoreP01AI127335 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI JAY A NELSON · 2017 to 2026
$24.6M
Stress Exacerbates Myocardial Ischemic Injury by Blocking Estrogen's Antidoxidant Protection in the Female HeartP20GM121307 · NIGMS · LOUISIANA STATE UNIV HSC SHREVEPORT · PI Christopher G Kevil · 2018 to 2026
$23.6M
Project 4-Tracking cytomegalovirus-primed long-lived NK cells in salivary glandP20GM134974 · NIGMS · LOUISIANA STATE UNIV HSC SHREVEPORT · PI ANDREW D YUROCHKO · 2021 to 2026
$15.0M
Analysis of HCMV Infection of Monocytes and MacrophagesR01AI056077 · NIAID · LOUISIANA STATE UNIV HSC SHREVEPORT · PI YUROCHKO, ANDREW D · 2004 to 2020
$4.7M
CSE regulation of vascular remodelingR01HL149264 · NHLBI · LOUISIANA STATE UNIV HSC SHREVEPORT · PI KEVIL, CHRISTOPHER G · 2020 to 2023
$1.7M
HCMV receptors, signaling and entryR56AI159672 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI KOWALIK, TIMOTHY F, YUROCHKO, ANDREW D · 2022 to 2022
$532k
NHLBI NIH HHS R01 HL149264NIAID NIH HHS P01 AI127335NIAID NIH HHS R01 AI056077NIAID NIH HHS R56 AI159672NIGMS NIH HHS P20 GM121307NIGMS NIH HHS P20 GM134974NIGMS NIH HHS U54 GM104940
6 · The paper itself

Abstract

Wastewater surveillance has proven to be a useful tool for evidence-based epidemiology in the fight against the SARS-CoV-2 virus. It is particularly useful at the population level where acquisition of individual test samples may be time or cost-prohibitive. Wastewater surveillance for SARS-CoV-2 has typically been performed at wastewater treatment plants; however, this study was designed to sample on a local level to monitor the spread of the virus among three communities with distinct social vulnerability indices in Shreveport, Louisiana, located in a socially vulnerable region of the United States. Twice-monthly grab samples were collected from September 30, 2020, to March 23, 2021, during the Beta wave of the pandemic. The goals of the study were to examine whether: 1) concentrations of SARS-CoV-2 RNA in wastewater varied with social vulnerability indices and, 2) the time lag of spikes differed during wastewater monitoring in the distinct communities. The size of the population contributing to each sample was assessed via the quantification of the pepper mild mottle virus (PMMoV), which was significantly higher in the less socially vulnerable community. We found that the communities with higher social vulnerability exhibited greater viral loads as assessed by wastewater when normalized with PMMoV (Kruskal-Wallis, p < 0.05). The timing of the spread of the virus through the three communities appeared to be similar. These results suggest that interconnected communities within a municipality experienced the spread of the SARS-CoV-2 virus at similar times, but areas of high social vulnerability experienced more intense wastewater viral loads.

Indexed as

COVID-19HumansRNA, ViralSARS-CoV-2TobamovirusViral LoadWastewaterWastewater-Based Epidemiological MonitoringRNA, ViralWastewaterPMMoV-normalized SARS-CoV-2Targeted wastewater surveillanceWastewaterWBEWWTP

Identifiers

PMID36709030
PMCPMC9877155
OpenAlexW4318052054

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.